MGMT and central nervous system cancer: Further observations on quantitative assays for MGMT mRNA and quantitative MGMT methylation levels will accomplish the role of MGMT expression as biomarker predicting the response to alkylating chemotherapy, in order to provide more rational bases for decisions on the therapeutic options available for patients affected by glioma.